E-LIB Suche - Ergebnisse für: TYRING, S

1

Quality of life and patient‐perceived symptoms in patients ..:

Jalili, A. ; Calzavara‐Pinton, P. ; Kircik, L....
Journal of the European Academy of Dermatology and Venereology. 36 (2021) 1 - p. 60-67 , 2021

Link: https://doi.org/10.1111/..

2

Hailey–Hailey disease treated with dupilumab: a case series:

Alzahrani, N. ; Grossman‐Kranseler, J. ; Swali, R....
British Journal of Dermatology. 185 (2021) 3 - p. 680-682 , 2021

Link: https://doi.org/10.1111/..

3

ASN002 demonstrates efficacy and improves inflammation in A:

Bissonnette, R. ; Maari, C. ; Forman, S....
British Journal of Dermatology. 181 (2019) 4 - p. , 2019

Link: https://doi.org/10.1111/..

4

阿达木单抗在斑块型银屑病成人患者中的长期安全性:

Leonardi, C. ; Papp, K. ; Strober, B....
British Journal of Dermatology. 180 (2019) 1 - p. e26-e26 , 2019

Link: https://doi.org/10.1111/..

5

The oral Janus kinase/spleen tyrosine kinase inhibitorASN00..:

Bissonnette, R. ; Maari, C. ; Forman, S....
British Journal of Dermatology. 181 (2019) 4 - p. 733-742 , 2019

Link: https://doi.org/10.1111/..

6

Long‐term safety of adalimumab in adult patients with plaqu..:

Leonardi, C. ; Papp, K. ; Strober, B....
British Journal of Dermatology. 180 (2019) 1 - p. e13-e13 , 2019

Link: https://doi.org/10.1111/..

7

Brodalumab in patients who had inadequate response to ustek..:

Langley, R.G. ; Armstrongi, A.W. ; Lebwohl, M.G....
British Journal of Dermatology. 180 (2019) 2 - p. e40-e40 , 2019

Link: https://doi.org/10.1111/..

8

Tildrakizumab efficacy and impact on quality of life up to ..:

Blauvelt, A. ; Sofen, H. ; Papp, K....
Journal of the European Academy of Dermatology and Venereology. 33 (2019) 12 - p. 2305-2312 , 2019

Link: https://doi.org/10.1111/..

9

Brodalumab 用于对乌司奴单抗应答不足的患者:

Langley, R.G. ; Armstrongi, A.W. ; Lebwohl, M.G....
British Journal of Dermatology. 180 (2019) 2 - p. e53-e53 , 2019

Link: https://doi.org/10.1111/..

10

ASN002 证明有疗效并可改善AD 炎症:

Bissonnette, R. ; Maari, C. ; Forman, S....
British Journal of Dermatology. 181 (2019) 4 - p. , 2019

Link: https://doi.org/10.1111/..

11

Efficacy and safety of brodalumab in patients with psoriasi..:

Langley, R.G. ; Armstrong, A.W. ; Lebwohl, M.G....
British Journal of Dermatology. 180 (2018) 2 - p. 306-314 , 2018

Link: https://doi.org/10.1111/..

12

Efficacité et tolérance du risankizumab dans le psoriasis e..:

Blauvelt, A. ; Papp, K. ; Gooderham, M....
Annales de Dermatologie et de Vénéréologie. 145 (2018) 12 - p. S355-S356 , 2018

Link: https://doi.org/10.1016/..

13

Comprehensive long‐term safety of adalimumab from 18 clinic..:

Leonardi, C. ; Papp, K. ; Strober, B....
British Journal of Dermatology. 180 (2018) 1 - p. 76-85 , 2018

Link: https://doi.org/10.1111/..

14

Évaluation de l'efficacité du secukinumab (blanchiment des ..:

Blauvelt, A. ; Puig, L. ; Reich, K....
Annales de Dermatologie et de Vénéréologie. 144 (2017) 12 - p. S261-S262 , 2017

Link: https://doi.org/10.1016/..

15

Open-label study of etanercept treatment in patients with m..:

Bagel, J. ; Tyring, S. ; Rice, K.C....
British Journal of Dermatology. 177 (2017) 2 - p. 411-418 , 2017

Link: https://doi.org/10.1111/..